News Releases

August 4, 2026

Certara Reports Second Quarter 2026 Financial Results

July 15, 2026

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

July 7, 2026

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit

June 17, 2026

Certara Announces CFO Transition

May 18, 2026

Certara to Participate in Upcoming Investor Conferences

May 11, 2026

Certara Reports First Quarter 2026 Financial Results

April 22, 2026

Certara Enters Definitive Agreement for the Sale of its Regulatory Writing and Medical Writing Business to Veristat

April 9, 2026

Certara to Report First Quarter 2026 Financial Results on May 11th, 2026

March 3, 2026

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

February 27, 2026

Certara to Participate in Upcoming Investor Conferences